Clinical Trials Insight: 700014187
Phase of Trial: Phase III
Latest Information Update: 22 Jul 2010
At a glance
- Drugs Doxepin (Primary)
- Indications Insomnia
- Focus Registrational; Therapeutic Use
- Sponsors Somaxon Pharmaceuticals
- 22 Jul 2010 Results reported in a Somaxon Pharmaceuticals media release. Results will also be published in Sleep.
- 20 May 2009 Results presented at the 162nd Annual Meeting of the American Psychiatric Association (APA 2009).
- 07 May 2008 Results data have been reported in a Somaxon media release.